U.S. flag

An official website of the United States government

NM_001139.3(ALOX12B):c.1562A>G (p.Tyr521Cys) AND Lamellar ichthyosis

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Mar 4, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002222361.2

Allele description [Variation Report for NM_001139.3(ALOX12B):c.1562A>G (p.Tyr521Cys)]

NM_001139.3(ALOX12B):c.1562A>G (p.Tyr521Cys)

Gene:
ALOX12B:arachidonate 12-lipoxygenase, 12R type [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
17p13.1
Genomic location:
Preferred name:
NM_001139.3(ALOX12B):c.1562A>G (p.Tyr521Cys)
HGVS:
  • NC_000017.11:g.8075687T>C
  • NG_007099.2:g.17030A>G
  • NM_001139.3:c.1562A>GMANE SELECT
  • NP_001130.1:p.Tyr521Cys
  • LRG_1264t1:c.1562A>G
  • LRG_1264:g.17030A>G
  • LRG_1264p1:p.Tyr521Cys
  • NC_000017.10:g.7979005T>C
  • NG_007099.1:g.17017A>G
  • NM_001139.2:c.1562A>G
  • O75342:p.Tyr521Cys
Protein change:
Y521C; TYR521CYS
Links:
UniProtKB: O75342#VAR_069556; OMIM: 603741.0012; dbSNP: rs199766569
NCBI 1000 Genomes Browser:
rs199766569
Molecular consequence:
  • NM_001139.3:c.1562A>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Lamellar ichthyosis
Identifiers:
MONDO: MONDO:0017778; MedGen: C5848247

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002500082Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Pathogenic
(Mar 4, 2022)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Mutation spectrum and functional analysis of epidermis-type lipoxygenases in patients with autosomal recessive congenital ichthyosis.

Eckl KM, Krieg P, Küster W, Traupe H, André F, Wittstruck N, Fürstenberger G, Hennies HC.

Hum Mutat. 2005 Oct;26(4):351-61.

PubMed [citation]
PMID:
16116617

Spectrum of Autosomal Recessive Congenital Ichthyosis in Scandinavia: Clinical Characteristics and Novel and Recurrent Mutations in 132 Patients.

Pigg MH, Bygum A, Gånemo A, Virtanen M, Brandrup F, Zimmer AD, Hotz A, Vahlquist A, Fischer J.

Acta Derm Venereol. 2016 Nov 2;96(7):932-937. doi: 10.2340/00015555-2418.

PubMed [citation]
PMID:
27025581

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV002500082.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)

Description

Variant summary: ALOX12B c.1562A>G (p.Tyr521Cys) results in a non-conservative amino acid change located in the Lipoxygenase, C-terminal domain (IPR013819) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00019 in 251486 control chromosomes. This frequency is not significantly higher than expected for a pathogenic variant in ALOX12B causing Lamellar Ichthyosis (0.00019 vs 0.0009), allowing no conclusion about variant significance. c.1562A>G has been reported in the literature as homozygous and compound heterozygous genotypes in multiple individuals affected with Lamellar Ichthyosis (example, Pigg_2016, Eckl_2005). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no variant specific traceable experimental evidence demonstrating an impact on protein function has been reported. Although one study reported no enzyme activity, the primary data supporting this evidence were not presented (Eckl_2005). Seven clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 20, 2024